All In MedTech

Device Trial Radar · NCT06627673

MultiCenter IDE Study of the PEEK-OPTIMA™ Femoral Component vs a CoCr Alloy TKA Femoral Component of Similar Design

MultiCenter Prospective Parallel Registry Controlled Investigational Device Exemption Clinical Study to Determine Non-Inferiority of the PEEK-OPTIMA™ Femoral Component Versus a CoCr Alloy Femoral Component of Similar Design for TKA

Last checked: Nov 20, 2026Latest source record: Jun 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Jan 1, 2026

Primary completion

Jan 1, 2029

Study completion Mar 1, 2029

Sponsor

Lead sponsor
Maxx Orthopedics IncNot on our public-company list
Sponsor type
Industry
First posted
Oct 4, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this investigational device exemption (IDE) study is to monitor the performance (safety and efficacy) of the Maxx Orthopedics, Freedom Total Knee® System, with a femoral component of similar design, manufactured from polyether-ether-ketone (PEEK).

Conditions

  • Knee Osteoarthritis

Interventions

  • Total Knee ArthroplastyDevice

    Primary Total Knee Arthroplasty with a PEEK femoral component

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Original Knee Society ScoreTime frame: 24 months post-treatment.

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Ascentis

    Leawood, Kansas · Recruiting

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.